|
1
|
Zhou L, Azfer A, Niu J, Graham S,
Choudhury M, Adamski FM, Younce C, Binkley PF and Kolattukudy PE:
Monocyte chemoattractant protein-1 induces a novel transcription
factor that causes cardiac myocyte apoptosis and ventricular
dysfunction. Circ Res. 98:1177–1185. 2006. View Article : Google Scholar
|
|
2
|
Vrotsos EG, Kalattukudy PE and Sugaya K:
MCP-1 involvement in glial differentiation of neuroprogenitor cells
through APP signaling. Brain Res Bull. 79:97–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsushita K, Takeuchi O, Standley DM,
Kumagai Y, Kawagoe T, Miyake T, Satoh T, Kato H, Tsujimura T,
Nakamura H and Akira S: Zc3h12a is an RNase essential for
controlling immune responses by regulating mRNA decay. Nature.
458:1185–1190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizgalska D, Wegrzyn P, Murzyn K, Kasza A,
Koj A and Jura J, Jarząb B and Jura J: Interleukin-1-inducible
MCPIP protein has structural and functional properties of RNase
participating in degradation of IL-1β mRNA. FEBS J. 276:7386–7399.
2009.PubMed/NCBI
|
|
5
|
Liang J, Saad Y, Lei T, Wang J, Qi D, Yang
Q, Kolattukudy PE and Fu M: MCP-induced protein 1 deubiquitinates
TRAF proteins and negatively regulates JNK and NF-κB signaling. J
Exp Med. 207:2959–2973. 2010.PubMed/NCBI
|
|
6
|
Jura J, Węgrzyn P, Korostyński M, Guzik K,
Oczko-Wojciechowska M, Jarząb M, Kowalska M, Piechota M, Przewłocki
R and Koj A: Identification of interleukin-1 and
interleukin-6-responsive genes in human monocyte-derived
macrophages using microarrays. Biochim Biophys Acta. 1799:383–389.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang J, Wang J, Azfer A, Song W, Tromp G,
Kolattukudy PE and Fu M: A novel CCCH-zinc finger protein family
regulates proinflammatory activation of macrophages. J Biol Chem.
283:6337–6346. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jura J, Skalniak Ł and Koj A:
Monocyte-chemotactic protein-1-induced protein-1 (MCPIP1) is a
novel multifunctional modulator of inflammatory reactions. Biochim
Biophys Acta. 1823:1905–1913. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin RJ, Chien HL, Lin SY, Chang BL, Yu HP,
Tang WC and Lin YL: MCPIP1 ribonuclease exhibits broad-spectrum
antiviral effects through viral RNA binding and degradation.
Nucleic Acids Res. 41:3314–3326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Skalniak L, Koj A and Jura J: Proteasome
inhibitor MG-132 induces MCPIP1 expression. FEBS J. 280:2665–2674.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki HI, Arase M, Matsuyama H, Choi YL,
Ueno T, Mano H, Sugimoto K and Miyazono K: MCPIP1 ribonuclease
antagonizes dicer and terminates microRNA biogenesis through
precursor microRNA degradation. Mol Cell. 44:424–436. 2011.
View Article : Google Scholar
|
|
12
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–170. 2009. View Article : Google Scholar
|
|
13
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant protein-1 (MCP-1): an overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muramatsu T and Muramatsu H:
Glycosaminoglycan-binding cytokines as tumor markers. Proteomics.
8:3350–3359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Łastowska M, Viprey V, Santibanez-Koref M,
Wappler I, Peters H, Cullinane C, Roberts P, Hall AG, Tweddle DA,
Pearson ADJ, Lewis I, Burchill SA and Jackson MS: Identification of
candidate genes involved in neuroblastoma progression by combining
genomic and expression microarrays with survival data. Oncogene.
26:7432–7444. 2007.PubMed/NCBI
|
|
16
|
Kool M, Koster J, Bunt J, Hasselt NE,
Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J,
Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D,
Clifford SC and Versteeg R: Integrated genomics identifies five
medulloblastoma subtypes with distinct genetic profiles, pathway
signatures and clinicopathological features. PLoS One. 3:e30882008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paugh BS, Qu C, Jones C, Liu Z,
Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D,
Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG and
Baker SJ: Integrated molecular genetic profiling of pediatric
high-grade gliomas reveals key differences with the adult disease.
J Clin Oncol. 28:3061–3068. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnson RA, Wright KD, Poppleton H,
Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E,
Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B,
Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC,
Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD,
Grundy RG and Gilbertson RJ: Cross-species genomics matches driver
mutations and cell compartments to model ependymoma. Nature.
466:632–636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bogenmann E: A metastatic neuroblastoma
model in SCID mice. Int J Cancer. 67:379–385. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gauthier ER, Madison SD and Michel RN:
Rapid RNA isolation without the use of commercial kits: application
to small tissue samples. Eur J Physiol. 433:664–668. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith PK: Measurement of protein using
bicinchoninic acid. Anal Biochem. 150:76–85. 1985. View Article : Google Scholar
|
|
22
|
Pomerantz JL and Baltimore D: Two pathways
to NF-κB. Mol Cell. 10:693–695. 2002.
|
|
23
|
Ueda A, Ishigatsubo Y, Okubo T and
Yoshimura T: Transcriptional regulation of the human monocyte
chemoattractant protein-1 gene. Cooperation of two NF-κB sites and
NF-κB/Rel subunit specificity. J Biol Chem. 272:31092–31099.
1997.PubMed/NCBI
|
|
24
|
Skalniak L, Mizgalska D, Zarebski A,
Wyrzykowska P, Koj A and Jura J: Regulatory feedback loop between
NF-κB and MCP-1-induced protein 1 RNase. FEBS J. 276:5892–5905.
2009.
|
|
25
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ora I and Eggert A: Progress in treatment
and risk stratification of neuroblastoma: Impact on future clinical
and basic research. Semin Cancer Biol. 21:217–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi
Z, Asgharzadeh S, Groshen S, Wilson SB and Seeger RC: Natural
killer T cells infiltrate neuroblastomas expressing the chemokine
CCL2. J Exp Med. 199:1213–1221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song L, Ara T, Wu HW, Woo CW, Reynolds CP,
Seeger RC, DeClerck YA, Thiele CJ, Sposto R and Metelitsa LS:
Oncogene MYCN regulates localization of NKT cells to the site of
disease in neuroblastoma. J Clin Invest. 117:2702–2712. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iwasaki H, Takeuchi O, Teraguchi S,
Matsushita K, Uehata T, Kuniyoshi K, Satoh T, Saitoh T, Matsuhita
M, Standley DM and Akira S: The IκB kinase complex regulates the
stability of cytokine-encoding mRNA induced by TLR-IL-1R by
controlling degradation of regnase-1. Nat Immunol. 12:1167–1175.
2011.
|
|
31
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu J, Fu S, Peng W and Rao Z:
MCP-1-induced protein-1, an immune regulator. Protein Cell.
3:903–910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Clissold PM and Ponting CP: PIN domain in
nonsense-mediated mRNA decay and RNAi. Curr Biol. 10:R888–R890.
2000. View Article : Google Scholar : PubMed/NCBI
|
